13.86
price down icon4.81%   -0.69
 
loading

Zymeworks Inc. Borsa (ZYME) Ultime notizie

pulisher
08:57 AM

FDA Greenlights Jazz Pharma's Cancer Drug, A Milestone For Zymework - Benzinga

08:57 AM
pulisher
07:46 AM

Zymeworks to Showcase Innovations at Investor Conferences - TipRanks

07:46 AM
pulisher
06:07 AM

Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewswire

06:07 AM
pulisher
06:05 AM

Zymeworks to Present at Major Healthcare Conferences, Announces R&D Day for Pipeline Updates | ZYME Stock News - StockTitan

06:05 AM
pulisher
06:01 AM

FDA Grants U.S. Approval of Ziihera® (zanidatamab-hrii) for - GlobeNewswire

06:01 AM
pulisher
06:00 AM

FDA Grants U.S. Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC) - GlobeNewswire Inc.

06:00 AM
pulisher
Nov 20, 2024

Leerink Partners Upgrades Zymeworks (ZYME) - MSN

Nov 20, 2024
pulisher
Nov 15, 2024

Redmile Group, LLC Adjusts Stake in Zymeworks Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 12, 2024

Zymeworks stock soars to 52-week high, hits $17.29 By Investing.com - Investing.com Australia

Nov 12, 2024
pulisher
Nov 11, 2024

Zymeworks stock soars to 52-week high, hits $17.29 - Investing.com India

Nov 11, 2024
pulisher
Nov 11, 2024

Zymeworks (NYSE:ZYME) Stock Rating Upgraded by Leerink Partners - Defense World

Nov 11, 2024
pulisher
Nov 11, 2024

FY2024 EPS Estimates for Zymeworks Lifted by Leerink Partnrs - MarketBeat

Nov 11, 2024
pulisher
Nov 09, 2024

Analysts Update Their Estimates For Zymeworks BC Inc - Stocks Register

Nov 09, 2024
pulisher
Nov 09, 2024

Q4 Earnings Estimate for Zymeworks Issued By Leerink Partnrs - Defense World

Nov 09, 2024
pulisher
Nov 09, 2024

Zymeworks (NYSE:ZYME) Raised to Strong-Buy at Leerink Partnrs - Defense World

Nov 09, 2024
pulisher
Nov 08, 2024

Leerink Partnrs Forecasts Zymeworks' Q4 Earnings (NYSE:ZYME) - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Zymeworks Inc. (NYSE:ZYME) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Optimistic Investors Push Zymeworks Inc. (NASDAQ:ZYME) Shares Up 34% But Growth Is Lacking - Simply Wall St

Nov 08, 2024
pulisher
Nov 08, 2024

Zymeworks (NYSE:ZYME) Upgraded to "Strong-Buy" at Leerink Partnrs - MarketBeat

Nov 08, 2024
pulisher
Nov 07, 2024

Leerink lifts Zymeworks stock target on pipeline progress By Investing.com - Investing.com Nigeria

Nov 07, 2024
pulisher
Nov 07, 2024

Leerink lifts Zymeworks stock target on pipeline progress - Investing.com

Nov 07, 2024
pulisher
Nov 06, 2024

Zymeworks doses first subject in Phase I trial of ZW191 for solid tumours - Clinical Trials Arena

Nov 06, 2024
pulisher
Nov 06, 2024

Citigroup Increases Zymeworks (NYSE:ZYME) Price Target to $18.00 - Defense World

Nov 06, 2024
pulisher
Nov 05, 2024

Zymeworks Announces First Patient Dosed in Phase 1 Clinical - GlobeNewswire

Nov 05, 2024
pulisher
Nov 05, 2024

Zymeworks Launches Phase 1 Trial for ZW191 - TipRanks

Nov 05, 2024
pulisher
Nov 05, 2024

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW191 in Folate Receptor-⍺ Expressing Advanced Solid Tumors - The Manila Times

Nov 05, 2024
pulisher
Nov 05, 2024

Zymeworks (NYSE:ZYME) Sets New 52-Week High Following Analyst Upgrade - Defense World

Nov 05, 2024
pulisher
Nov 04, 2024

Zymeworks stock soars to 52-week high of $14.08 amid robust gains - Investing.com Canada

Nov 04, 2024
pulisher
Nov 04, 2024

Zymeworks: Turning The Tide With 2 Key Milestones For Zanidatamab (NASDAQ:ZYME) - Seeking Alpha

Nov 04, 2024
pulisher
Nov 04, 2024

Zymeworks (NYSE:ZYME) Cut to Equal Weight at Wells Fargo & Company - Defense World

Nov 04, 2024
pulisher
Nov 04, 2024

Zymeworks’ (ZYME) “Neutral” Rating Reiterated at HC Wainwright - Defense World

Nov 04, 2024
pulisher
Nov 03, 2024

Zymeworks Inc. (NASDAQ:ZYME) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - Simply Wall St

Nov 03, 2024
pulisher
Nov 03, 2024

Wells Fargo Downgrades Zymeworks (ZYME) - MSN

Nov 03, 2024
pulisher
Nov 03, 2024

Zymeworks (NYSE:ZYME) Shares Gap Down – Here’s What Happened - Defense World

Nov 03, 2024
pulisher
Nov 02, 2024

Zymeworks Inc. (NYSE:ZYME) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 02, 2024
pulisher
Nov 02, 2024

Zymeworks Q4 2024 Earnings Preview - MSN

Nov 02, 2024
pulisher
Nov 01, 2024

Zymeworks to Spotlight Innovations at Investor Conferences - MSN

Nov 01, 2024
pulisher
Nov 01, 2024

Earnings call: Zymeworks reports Q3 2024 results and pipeline progress - Investing.com

Nov 01, 2024
pulisher
Nov 01, 2024

Zymeworks (NYSE:ZYME) Shares Gap DownHere's Why - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Zymeworks stock downgraded at Wells Fargo (ZYME:NASDAQ) - Seeking Alpha

Nov 01, 2024
pulisher
Nov 01, 2024

Time To Worry? Analysts Are Downgrading Their Zymeworks Inc. (NASDAQ:ZYME) Outlook - Simply Wall St

Nov 01, 2024
pulisher
Nov 01, 2024

Zymeworks Inc. (NASDAQ:ZYME) Analysts Are Reducing Their Forecasts For Next Year - Yahoo Finance

Nov 01, 2024
pulisher
Nov 01, 2024

HC Wainwright Reiterates Neutral Rating for Zymeworks (NYSE:ZYME) - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Zymeworks Inc. (ZYME) Reports Q3 Loss, Lags Revenue Estimates - MSN

Nov 01, 2024
pulisher
Nov 01, 2024

Zymeworks Inc (ZYME) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - Yahoo Finance

Nov 01, 2024
pulisher
Nov 01, 2024

Zymeworks Reports Q3 Results and Strategic Advances - TipRanks

Nov 01, 2024
pulisher
Oct 31, 2024

Zymeworks Advances Biotherapeutic Pipeline in 2024 - TipRanks

Oct 31, 2024
pulisher
Oct 31, 2024

Zymeworks Provides Corporate Update and Reports Third Quarter 2024 Financial Results - The Manila Times

Oct 31, 2024
pulisher
Oct 31, 2024

Zymeworks Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Oct 31, 2024
pulisher
Oct 31, 2024

Zymeworks Q3 2024 Earnings Preview - MSN

Oct 31, 2024
pulisher
Oct 30, 2024

Zymeworks Inc (ZYME) Q3 2024 Earnings Report Preview: What To Lo - GuruFocus.com

Oct 30, 2024
pulisher
Oct 30, 2024

Zymeworks (NYSE:ZYME) PT Raised to $28.00 at Stifel Nicolaus - Defense World

Oct 30, 2024
pulisher
Oct 30, 2024

Assenagon Asset Management S.A. Takes Position in Zymeworks Inc. (NYSE:ZYME) - MarketBeat

Oct 30, 2024
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):